Essential Premium

It’s Biopharma or Bust for the IPO Market

The first three companies expected to go public this month are all health care–related, reinforcing the sector’s dominance in a slow new issue market.

Heads of Distribution Roundtable

January 19-21, 2027 | The St. Regis Aspen

Leaders of the University of Illinois Foundation Defend Portfolio Overhaul

“We’re in a much better position regardless of what happens in the economy.”

Sponsored

Your Alternatives Need an Alternative

Financing the World’s Essential Assets: The Growing Opportunity in Infrastructure Debt

After a Record 2025, Chris Hohn Is Still Digging Out of a Slump

But Chris Hohn’s concentrated long portfolio is nearing profitability again after generating more profits for its investors than any other firm last year.

Related Content

Biopharma Continues to Buoy the IPO Market

Stephen Taub

AI is Driving the Venture Capital Market — But Not Fixing It

Michelle Celarier

OpenAI Backers Include Hedge Fund Heavyweights Poised for IPO Payoff

Stephen Taub

CIO Roundtable 2027

March 10-11, 2027 | Pier Sixty-Six

1270 Avenue of the Americas, Suite 1120

New York, NY 10020

 

© Institutional Investor, LLC. All material subject to strictly enforced copyright laws. Please read our Terms and Conditions and Privacy Policy before using the site.

 

| Unsubscribe

LinkedIn
X (Twitter)
Bluesky
Instagram